Integra Lifesciences IART
$13.25 −$0.30 (-2.21%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $12.99 -1.96%
Open$13.38
Prev close$13.55
Day range$13.16 – $13.79
Volume828.6K
Market cap$1.03B
P/E (TTM)77.9
Dividend yield–
IART Stock News
Headlines matching Integra Lifesciences or the IART ticker, most recent first.
- J.P. Morgan Maintains Integra Lifesciences(IART.US) With Sell Rating, Raises Target Price to $17 Positive
- Citi Maintains Integra Lifesciences(IART.US) With Hold Rating, Maintains Target Price $19
- BMO Capital Maintains Integra Lifesciences(IART.US) With Hold Rating, Cuts Target Price to $18 Negative
- Wells Fargo Maintains Integra Lifesciences(IART.US) With Hold Rating, Raises Target Price to $18 Positive
- Truist Financial Maintains Integra Lifesciences(IART.US) With Hold Rating, Raises Target Price to $19 Positive
- BMO Capital Maintains Integra Lifesciences(IART.US) With Hold Rating, Announces Target Price $19
- Argus Research Upgrades Integra Lifesciences(IART.US) to Buy Rating, Announces Target Price $25 Positive
- Wells Fargo Maintains Integra Lifesciences(IART.US) With Hold Rating, Raises Target Price to $15 Positive
- Citi Maintains Integra Lifesciences(IART.US) With Sell Rating, Raises Target Price to $11 Positive
- Citi Upgrades Integra Lifesciences(IART.US) to Hold Rating, Raises Target Price to $16 Positive
- BofA Securities Initiates Integra Lifesciences(IART.US) With Sell Rating
- Analysts Offer Insights on Healthcare Companies: Kairos Pharma, Ltd. (KAPA), Integra Lifesciences (IART) and Biogen (BIIB)
- Citi Maintains Integra Lifesciences(IART.US) With Sell Rating, Maintains Target Price $9
- Argus Research Downgrades Integra Lifesciences(IART.US) to Hold Rating Negative
- Truist Financial Maintains Integra Lifesciences(IART.US) With Hold Rating, Cuts Target Price to $12 Negative
No comments yet — be the first to weigh in on IART.
Sign in to join the discussion.